UA

Umesh Anantha Padmanabha Bisile

Active Director Director DIN 02803382
DIN 02803382 First appointment Apr 2011 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Apr 2011
Shareholding value •••• Premium profile

About Umesh Anantha Padmanabha Bisile

Data last updated:

Umesh Anantha Padmanabha Bisile has 15 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 3 companies, including Zumanta Pharma Private Limited and Nextbio Research Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹19.29 Cr; the largest is Invitro Research Solutions Private Limited at ₹19.28 Cr (FY 2023).

DIN 02803382
Primary Designation Director
First Appointment 25 Apr 2011
Oldest Company Age 15 yrs
Largest company Invitro Research Solutions Private Limited · ₹19.28 Cr (FY 2023)
Combined revenue ₹19.29 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director26 Feb 20212016₹19.28 Cr (FY 2023)Active
Director18 Jul 20222022₹24,879 (FY 2025)Active
Nextbio Research Private Limited U73100KA2016PTC095455
Director02 Aug 20162016₹23,809 (FY 2022)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zumanta Pharma Private Limited U73100KA2011PTC058292
Director25 Apr 20112011₹3.5 Lakh (FY 2017)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zumanta Pharma Private Limited
Nextbio Research Private Limited
Biostec Data Safety Services Private Limited
Invitro Research Solutions Private Limited
Premium access

Shareholding and investment profile for Umesh Anantha Padmanabha Bisile

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Umesh Anantha Padmanabha Bisile

Umesh Anantha Padmanabha Bisile has 15 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 3 companies, including Zumanta Pharma Private Limited and Nextbio Research Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹19.29 Cr; the largest is Invitro Research Solutions Private Limited at ₹19.28 Cr (FY 2023).

Umesh Anantha Padmanabha Bisile is associated with 3 companies as Director and Whole-Time Director, including Invitro Research Solutions Private Limited (₹19.28 Cr), Biostec Data Safety Services Private Limited (₹24,879), Nextbio Research Private Limited (₹23,809).

Umesh Anantha Padmanabha Bisile has expertise in General Business.

Umesh Anantha Padmanabha Bisile has 15 years in corporate governance.

By reported revenue, the largest current company of Umesh Anantha Padmanabha Bisile is Invitro Research Solutions Private Limited, with revenue of ₹19.28 Cr (FY 2023).

The 3 current companies of Umesh Anantha Padmanabha Bisile that report revenue have a combined latest revenue of ₹19.29 Cr.

Umesh Anantha Padmanabha Bisile currently holds positions at 3 companies: Invitro Research Solutions Private Limited (₹19.28 Cr), Biostec Data Safety Services Private Limited (₹24,879), Nextbio Research Private Limited (₹23,809).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available